跳至主要内容
临床试验/NCT01446094
NCT01446094Unknown4 期

Diagnostic Value of a Rapid Protocol Regadenoson Stress Cardiovascular Magnetic Resonance Scan for Detection of Coronary Artery Disease

Dipan Shah1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2011年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
Dipan Shah
入组人数
50
试验地点
1
主要终点
Profile of sensitivity, specificity, and diagnostic accuracy of rapid regadenoson stress CMR.

研究概览

简要总结

This study is designed to evaluate the feasibility and diagnostic performance of a novel rapid regadenoson stress CMR protocol for detecting of obstructive coronary artery disease.

详细描述

This is a single center, open-label, pilot study in subjects scheduled for invasive coronary angiography for evaluation of coronary artery disease. The primary objective is to evaluate the profile of sensitivity, specificity, and diagnostic accuracy of a novel rapid regadenoson stress CMR protocol for detection of >= 70 coronary artery stenosis on invasive coronary angiography. Additionally the objective will be to compare the time for performance of this novel rapid regadenoson stress CMR protocol in comparison to the standard stress CMR protocol.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 years or older
  • Scheduled for invasive coronary angiography

排除标准

  • Inability to give informed consent
  • Possible pregnancy (confirmed by urine test)
  • Women who are breastfeeding
  • Severe claustrophobia
  • Inability to lie flat for 20-30 minutes (the anticipated amount of time to complete the MRI procedure)
  • Individuals with cochlear implants
  • Individuals with non-MRI compatible aneurysm clips
  • Potential contraindications to regadenoson use due to:
  • Severe lung disease (active wheezing) Severe bradycardia (heart rate < 40 beats/min) Second- or third-degree atrioventricular heart block Sick sinus syndrome History of Long QT syndrome Severe hypotension (systolic BP < 80 mm Hg) Decompensated heart failure
  • Contraindication to administration of Gadolinium (Gd) based contrast agents (GBCA):
  • Stage 4 or 5 chronic kidney disease (eGFR < 30 ml/min/1.73 m2) Known allergy to GBCA
  • Special Considerations:
  • Although individuals who have an occupational history of welding, grinding, or other metal work will not be excluded from the study, they must undergo an orbital x-ray, to exclude any occult metal fragments, before they can participate in this study.

研究组 & 干预措施

single-arm

Other

Additional images collected during routine cardiac MRI (CMR) with diagnostic imaging agent, regadenoson.

干预措施: regadenoson (Drug)

结局指标

主要结局

Profile of sensitivity, specificity, and diagnostic accuracy of rapid regadenoson stress CMR.

时间窗: Up to 7 days

Evaluate the profile of sensitivity, specificity, and diagnostic accuracy of a rapid regadenoson stress CMR protocol for the detection of \>= 70% stenosis of a major epicardial coronary artery on invasive coronary angiography.

次要结局

  • Evaluate time for performance of rapid regadenoson stress CMR protocol.(Up to 7 days)

研究者

发起方
Dipan Shah
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dipan Shah

Director, Cardiac Magnetic Resonance Imaging

The Methodist Hospital Research Institute

研究点 (1)

Loading locations...

相似试验

Diagnostic Study of Rapid Regadenoson Stress... | 临床试验